The Current Status of Allogenic Islet Cell Transplantation

The Current Status of Allogenic Islet Cell Transplantation

Type 1 Diabetes (T1D) is an autoimmune destruction of pancreatic beta cells. The development of the Edmonton Protocol for islet transplantation in 2000 revolutionized T1D treatment and offered a glimpse at a cure for the disease. In 2022, the 20-year follow-up findings of islet cell transplantation...

Full description

Bibliographic Details
Main Authors: Zofia Czarnecka, Nidheesh Dadheech, Haide Razavy, Rena Pawlick, A. M. James Shapiro
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cells
Subjects:
type 1 diabetes
islet
allogenic
transplantation
stem cell
immunosuppression
Online Access:https://www.mdpi.com/2073-4409/12/20/2423

Similar Items

Similar Items